Metastatic hormone-sensitive prostate cancer Clinical Trials
Conditions / Metastatic hormone-sensitive prostate cancer
Delta Trials indexes 2 clinical trials for Metastatic hormone-sensitive prostate cancer in its publicly accessible dataset. Of these, 2 enrolling participants at this time and 0 trials have reached completion. This research takes place spanning 59 research sites around the world. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity has changed over time.
Trial Status
2
Total Trials
2
Recruiting
0
Completed
0
Other Active
0
Terminated since 2020
59
Study Locations
Browse by location (59 total)
- Lugo, Spain 1 trialAll trials in Lugo, Spain
- Seattle, United States 1 trialAll trials in Seattle, United States
- Olsztyn, Poland 1 trialAll trials in Olsztyn, Poland
- Boston, United States 1 trialAll trials in Boston, United States
- Barcelona, Spain 1 trialAll trials in Barcelona, Spain
- Marseille, France 1 trialAll trials in Marseille, France
- Bethesda, United States 1 trialAll trials in Bethesda, United States
- Hamburg, Germany 1 trialAll trials in Hamburg, Germany
- Kielce, Poland 1 trialAll trials in Kielce, Poland
- New Haven, United States 1 trialAll trials in New Haven, United States
- Montréal, Canada 1 trialAll trials in Montréal, Canada
- Quint-fonsegrives, France 1 trialAll trials in Quint-fonsegrives, France
- Badajoz, Spain 1 trialAll trials in Badajoz, Spain
- Multiple Locations, South Korea 1 trialAll trials in Multiple Locations, South Korea
- Halifax, Canada 1 trialAll trials in Halifax, Canada
- Tainan, Taiwan 1 trialAll trials in Tainan, Taiwan
- Syracuse, United States 1 trialAll trials in Syracuse, United States
- Atlanta, United States 1 trialAll trials in Atlanta, United States
- Vancouver, Canada 1 trialAll trials in Vancouver, Canada
- Skorzewo, Poland 1 trialAll trials in Skorzewo, Poland